MedTech Terms
    The authoritative reference
    All terms
    Investment & FinanceStartup LifecycleSPAC

    Special Purpose Acquisition Company

    A publicly traded shell company formed to raise capital through an IPO with the sole purpose of acquiring or merging with a private operating company.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 9, 2026

    Definition

    A Special Purpose Acquisition Company (SPAC) is a publicly traded shell company that raises capital in an IPO and then has a defined window (typically 18-24 months) to identify and merge with a private operating company in a 'de-SPAC' transaction. Several MedTech companies (e.g., Butterfly Network, Owlet, 23andMe) went public via SPAC during the 2020-2021 boom. The SEC's January 2024 final rule on SPACs materially raised disclosure and gatekeeper liability standards, dampening the market.
    What the regulation says
    SEC Final Rule on SPACs (January 2024) — enhanced disclosure of dilution, conflicts, and projections; clearer underwriter and target liability under Section 11.

    What this means in practice

    Post-2024, SPACs are no longer a faster or cheaper path to public markets for most MedTech companies. Many de-SPAC MedTechs traded poorly post-merger, reshaping investor appetite.
    Common pitfalls
    • Treating projections in the de-SPAC proxy as marketing rather than as Section 11 liability exposure.

    Primary references

    3 sources
    Link health: 3 verified· last checked 2026-05-09
    SEC·2NVCA·1
    1. 1
      SEC — SPAC Final Rule (2024)
      Verified
      SECsec.gov
    2. 2
      SEC Final Rule 33-11265 — SPACs, Shell Companies, and Projections
      Verified
      SECsec.gov
    3. 3
      NVCA Model Documents
      Verified
      NVCAnvca.org

    Inline markers like [1] jump to the matching reference above.